|
|
|
Volumn 27, Issue 6, 2000, Pages 623-625
|
|
Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
RAPAMYCIN;
CLINICAL TRIAL;
DRUG COST;
DRUG INTERACTION;
GRAFT REJECTION;
HISTOCOMPATIBILITY;
HUMAN;
IMMUNOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE ABSORPTION;
KIDNEY TRANSPLANTATION;
METHODOLOGY;
NURSE ATTITUDE;
PATIENT SELECTION;
RENAL REPLACEMENT THERAPY;
REVIEW;
SAFETY;
TREATMENT OUTCOME;
CLINICAL TRIALS;
DRUG COSTS;
DRUG INTERACTIONS;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINAL ABSORPTION;
KIDNEY TRANSPLANTATION;
NURSE'S ROLE;
PATIENT SELECTION;
RENAL DIALYSIS;
SAFETY;
SIROLIMUS;
TRANSPLANTATION IMMUNOLOGY;
TREATMENT OUTCOME;
|
|
EID: 33744998963
PISSN: 1526744X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (14)
|
